To include your compound in the COVID-19 Resource Center, submit it here.

Orally-delivered insulin: Phase II

Nobex completed five U.S. Phase II trials of chemically modified insulin

Read the full 118 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE